RETACRIT (20000 UI/0.5 ml Solution injectable en seringue préremplie) - Prescribing information


 
Drug details are not available in the selected language, the original text is displayed

Retacrit - Dosage, use, side effects and drug information


: Retacrit 20000 UI/0.5 ml sol. inj. s.c./i.v. ser. préremplie
Active substance: Epoétine Zêta 40000 UI/ml ()
ATC group: B03XA01 - erythropoietin
Manufacturer: Pfizer Europe MA E.E.I.G.
Forms: Solution injectable en seringue préremplie
:

Fatal error: Call to a member function fetch_all() on boolean in /var/www/pharmacum.eu/functions.php on line 496